SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

ABMDSell

Abiomed Inc

David M Weber · COO

$2.4M−5.0%Feb 18
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$607K−1.0%Feb 17
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$617K−1.0%Feb 17
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$1.3M−3.0%Feb 17
ABMDSell

Abiomed Inc

David M Weber · COO

$3.3M−7.0%Feb 9
ABMDSell

Abiomed Inc

Todd A Trapp · VP and CFO

$359K−7.0%Jan 7
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$7.7M−14.0%Nov 18
ABMDSell

Abiomed Inc

Michael R Minogue · Chair, President and CEO

$1.2M−1.0%Aug 25
ABMDSell

Abiomed Inc

Paul Thomas · Director

$219K−9.0%Aug 19
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$2.5M−4.0%Aug 19
ABMDSell

Abiomed Inc

Michael R Minogue · Chair, President and CEO

$11.0M−6.0%Aug 10
ABMDSell

Abiomed Inc

Michael R Minogue · Chair, President and CEO

$8.5M−5.0%Aug 6
ABMDSell

Abiomed Inc

Michael R Minogue · Chair, President and CEO

$8.1M−5.0%Jun 23
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$2.0M−4.0%May 20
ABMDSell

Abiomed Inc

David M Weber · COO

$4.0M−8.0%May 5
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$2.4M−4.0%Feb 18
ABMDSell

Abiomed Inc

Dorothy E Puhy · Director

$1.7M−26.0%Feb 3
ABMDSell

Abiomed Inc

Andrew J Greenfield · VP and Chief Commercial Officer

$1.6M−10.0%Feb 1
ABMDSell

Abiomed Inc

Andrew J Greenfield · VP and Chief Commercial Officer

$1.8M−10.0%Feb 1
ABMDSell

Abiomed Inc

Andrew J Greenfield · VP and Chief Commercial Officer

$2.1M−14.0%Dec 23
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$403K−1.0%Nov 19
ABMDSell

Abiomed Inc

Michael R Minogue · Chair, President and CEO

$30.9M−17.0%Aug 24
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$468K−1.0%Aug 20
ABMDSell

Abiomed Inc

Paul Thomas · Director

$607K−23.0%Aug 11
ABMDSell

Abiomed Inc

Dorothy E Puhy · Director

$2.1M−28.0%Jul 17
ABMDSell

Abiomed Inc

Dorothy E Puhy · Director

$1.9M−22.0%Jun 9
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$2.2M−6.0%May 6
ABMDSell

Abiomed Inc

Paul Thomas · Director

$304K−18.0%Mar 4
ABMDSell

Abiomed Inc

Paul Thomas · Director

$362K−15.0%Feb 12
ABMDSell

Abiomed Inc

David M Weber · COO

$1.7M−5.0%Aug 7
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$1.2M−2.0%May 10
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$7.2M−10.0%Feb 15
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$10.5M−13.0%Feb 6
ABMDSell

Abiomed Inc

David M Weber · COO

$8.4M−13.0%Jan 29
ABMDSell

Abiomed Inc

Michael G Howley · VP, Global Sales, Marketing

$4.3M−16.0%Sep 26
ABMDSell

Abiomed Inc

Andrew J Greenfield · VP Healthcare Solutions

$2.1M−9.0%Sep 26
ABMDSell

Abiomed Inc

Andrew J Greenfield · VP Healthcare Solutions

$1.8M−8.0%Aug 31
ABMDSell

Abiomed Inc

David M Weber · COO

$6.9M−11.0%Aug 1
ABMDSell

Abiomed Inc

Michael R Minogue · Chair, President and CEO

$46.2M−16.0%Jun 25
ABMDSell

Abiomed Inc

David M Weber · COO

$20.6M−21.0%Jun 19
ABMDSell

Abiomed Inc

Martin P Sutter · Director

$7.5M−2.0%May 9
ABMDSell

Abiomed Inc

Michael G Howley · VP, Global Sales, Marketing

$6.1M−27.0%May 9
ABMDSell

Abiomed Inc

William J Bolt · SVP, QA, Regulatory Affairs

$7.9M−28.0%May 9
ABMDSell

Abiomed Inc

Dorothy E Puhy · Director

$4.7M−29.0%May 9
ABMDSell

Abiomed Inc

Andrew J Greenfield · VP Healthcare Solutions

$5.4M−29.0%Feb 22
ABMDSell

Abiomed Inc

Dorothy E Puhy · Director

$1.1M−16.0%Nov 1
ABMDSell

Abiomed Inc

Michael G Howley · VP, Global Sales, Marketing

$1.8M−18.0%Nov 1
ABMDSell

Abiomed Inc

Andrew J Greenfield · VP Healthcare Solutions

$1.9M−19.0%Oct 4
ABMDSell

Abiomed Inc

Eric A Md Rose · Director

$143K−7.0%Sep 1
ABMDSell

Abiomed Inc

Eric A Md Rose · Director

$3.5M−65.0%Aug 28

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.